Ascendis Health: Director associate acquires shares in on-market transaction
On April 4, 2025, Ascendis Health Limited (JSE: ASC) disclosed that an associate of director Theunis de Bruyn engaged in securities dealings. The transaction, which occurred on March 31, 2025, involved the purchase of 119,586 ordinary shares at a price of ZAR82.00 per share, resulting in a total value of ZAR98,060.52. The transaction was conducted on-market by an associate of the director. Calibre Investment Holdings (Pty) Ltd, of which de Bruyn is both a director and a shareholder, was identified as the associate involved in the transaction. Ascendis Health confirmed that clearance was obtained in accordance with paragraph 3.66 of the JSE Limited Listings Requirements. Valeo Capital (Pty) Limited acted as the sponsor for the transaction.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when ASCENDIS HEALTH LIMITED publishes news
Free account required • Unsubscribe anytime